Thirona

Thirona provides AI-powered lung image analysis through its LungQ platform, which offers advanced segmentation and quantification of lung structures from CT scans. The company supports pharmaceutical partners in drug development for respiratory diseases like COPD and asthma, and provides imaging intelligence for minimally invasive pulmonary interventions. Their technology is used by hospitals and clinical research organizations to assess treatment efficacy and standardize quantitative CT metrics.